Dcgi Rsquo

Rediff.com » News » Dcgi Rsquo

News for Dcgi Rsquo

News
Business

India probes four cough syrups after 66 Gambian children's deaths

India's drug regulator has initiated a probe and sought further details from the WHO after the global health body issued an alert that cough syrups manufactured by an Indian firm could potentially......

SIIto test Novavax's Omicron-specific vaccine

The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for ‘examination, test, and analysis’,......

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

If things go according to plan, the vaccine would be available in the market by the end of this year. IMAGE: Kindly note that this image has been posted for representational purposes only.......

Novovax Covid vaccine likely to get nod in India ahead of US

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending......

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

India is not keen to ‘bow down’ to demands related to indemnity against legal liabilities in case any vaccine recipient develops severe adverse reactions post inoculation. Even as......

What is Schedule M and why it's mandatory for all pharma units

With an eye on improving quality assurance in the wake of increased global scrutiny on Indian pharma products, the Centre on Tuesday said that Schedule M of the Drugs and Cosmetics Act, 1940 will......

Regulatory woes torpedo PE/VC deals in e-pharma sector

With regulatory uncertainties clouding the future of online pharmacies, deals in the space are showing signs of slowdown, as also fresh investment from private-equity (PE) firms and venture......

How complex is the process of getting approval for a vaccine?

Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through......

Pandemic brings windfall for e-pharma companies

The online pharmacy market, which was worth about $512 million in 2018, is growing at a CAGR of 63 per cent and is expected to hit overall revenues of over $3.6 billion by 2022. Illustration:......

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective......

Rediff News

Dcgi Rsquo

News for Dcgi Rsquo

India probes four cough syrups after 66 Gambian children's deaths

SIIto test Novavax's Omicron-specific vaccine

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Novovax Covid vaccine likely to get nod in India ahead of US

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

What is Schedule M and why it's mandatory for all pharma units

Regulatory woes torpedo PE/VC deals in e-pharma sector

How complex is the process of getting approval for a vaccine?

Pandemic brings windfall for e-pharma companies

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS